Ras oncogenes and their downstream targets

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1773, Issue 8, 2007, Pages 1177-1195

  Rajalingam, Krishnaraj ^a   Schreck, Ralf ^a   Rapp, Ulf R ^a   Albert, Štefan ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Mitogenic cascade; Mutational activation; Oncogenic signaling; RAS; RAS effector pathways; Small GTPases

Indexed keywords

GUANOSINE TRIPHOSPHATASE; MICRORNA; RAS PROTEIN;

CARCINOGENESIS; CELL FUNCTION; ENZYME ACTIVATION; GENE MUTATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; VIRUS ONCOGENE;

ANIMALS; EVOLUTION, MOLECULAR; GENES, RAS; GENOMICS; HUMANS; MICRORNAS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MUTATION; NEOPLASMS; PROTEOMICS; RAS PROTEINS; SIGNAL TRANSDUCTION; TUMOR STEM CELLS;

EID: 34547160398     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2007.01.012     Document Type: Review

References (225)

1. Malumbres M., and Barbacid M. RAS oncogenes: the first 30 years. Nat. Rev., Cancer 3 (2003) 459-465
2. Colicelli J. Human RAS superfamily proteins and related GTPases. Sci. STKE 2004 (2004) RE13
3. Wennerberg K., Rossman K.L., and Der C.J. The Ras superfamily at a glance. J. Cell. Sci. 118 (2005) 843-846
4. Marte B.M., Rodriguez-Viciana P., Wennstrom S., Warne P.H., and Downward J. R-Ras can activate the phosphoinositide 3-kinase but not the MAP kinase arm of the Ras effector pathways. Curr. Biol. 7 (1997) 63-70
5. Rodriguez-Viciana P., Oses-Prieto J., Burlingame A., Fried M., and McCormick F. A phosphatase holoenzyme comprised of Shoc2/Sur8 and the catalytic subunit of PP1 functions as an M-Ras effector to modulate Raf activity. Mol. Cell 22 (2006) 217-230
6. Takahashi K., Mitsui K., and Yamanaka S. Role of ERas in promoting tumour-like properties in mouse embryonic stem cells. Nature 423 (2003) 541-545
7. Wittinghofer A., and Nassar N. How Ras-related proteins talk to their effectors. Trends Biochem. Sci. 21 (1996) 488-491
8. Goody R.S., Frech M., and Wittinghofer A. Affinity of guanine nucleotide binding proteins for their ligands: facts and artefacts. Trends Biochem. Sci. 16 (1991) 327-328
9. John J., Schlichting I., Schiltz E., Rosch P., and Wittinghofer A. C-terminal truncation of p21H preserves crucial kinetic and structural properties. J. Biol. Chem. 264 (1989) 13086-13092
10. Gideon P., John J., Frech M., Lautwein A., Clark R., Scheffler J.E., and Wittinghofer A. Mutational and kinetic analyses of the GTPase-activating protein (GAP)-p21 interaction: the C-terminal domain of GAP is not sufficient for full activity. Mol. Cell. Biol. 12 (1992) 2050-2056
11. Barbacid M. Ras genes. Annu. Rev. Biochem. 56 (1987) 779-827
12. Scheffzek K., Ahmadian M.R., Kabsch W., Wiesmuller L., Lautwein A., Schmitz F., and Wittinghofer A. The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants. Science 277 (1997) 333-338
13. Graham D.L., Eccleston J.F., and Lowe P.N. The conserved arginine in rho-GTPase-activating protein is essential for efficient catalysis but not for complex formation with Rho.GDP and aluminum fluoride. Biochemistry 38 (1999) 985-991
14. Daumke O., Weyand M., Chakrabarti P.P., Vetter I.R., and Wittinghofer A. The GTPase-activating protein Rap1GAP uses a catalytic asparagine. Nature 429 (2004) 197-201
15. De Antoni A., Schmitzova J., Trepte H.H., Gallwitz D., and Albert S. Significance of GTP hydrolysis in Ypt1p-regulated endoplasmic reticulum to Golgi transport revealed by the analysis of two novel Ypt1-GAPs. J. Biol. Chem. 277 (2002) 41023-41031
16. Wittinghofer A. Phosphoryl transfer in Ras proteins, conclusive or elusive?. Trends Biochem. Sci. 31 (2006) 20-23
17. Jekely G. Small GTPases and the evolution of the eukaryotic cell. BioEssays 25 (2003) 1129-1138
18. Bar-Sagi D., and Hall A. Ras and Rho GTPases: a family reunion. Cell 103 (2000) 227-238
19. Jiang S.Y., and Ramachandran S. Comparative and evolutionary analysis of genes encoding small GTPases and their activating proteins in eukaryotic genomes. Physiol. Genomics 24 (2006) 235-251
20. Valster A.H., Hepler P.K., and Chernoff J. Plant GTPases: the Rhos in bloom. Trends Cell Biol. 10 (2000) 141-146
21. Vernoud V., Horton A.C., Yang Z., and Nielsen E. Analysis of the small GTPase gene superfamily of Arabidopsis. Plant Physiol. 131 (2003) 1191-1208
22. Broek D., Samiy N., Fasano O., Fujiyama A., Tamanoi F., Northup J., and Wigler M. Differential activation of yeast adenylate cyclase by wild-type and mutant RAS proteins. Cell 41 (1985) 763-769
23. Onken B., Wiener H., Philips M.R., and Chang E.C. Compartmentalized signaling of Ras in fission yeast. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 9045-9050
24. Chubb J.R., and Insall R.H. Dictyostelium: an ideal organism for genetic dissection of Ras signalling networks. Biochim. Biophys. Acta 1525 (2001) 262-271
25. Goldberg J.M., Manning G., Liu A., Fey P., Pilcher K.E., Xu Y., and Smith J.L. The dictyostelium kinome-Analysis of the protein kinases from a simple model organism. PLoS Genet. 2 (2006) e38
26. Field M.C. Signalling the genome: the Ras-like small GTPase family of trypanosomatids. Trends Parasitol. 21 (2005) 447-450
27. Champion A., Kreis M., Mockaitis K., Picaud A., and Henry Y. Arabidopsis kinome: after the casting. Funct. Integr. Genomics 4 (2004) 163-187
28. Chang C. The ethylene signal transduction pathway in Arabidopsis: an emerging paradigm?. Trends Biochem. Sci. 21 (1996) 129-133
29. Leon J., Guerrero I., and Pellicer A. Differential expression of the ras gene family in mice. Mol. Cell. Biol. 7 (1987) 1535-1540
30. Muller R., Slamon D.J., Adamson E.D., Tremblay J.M., Muller D., Cline M.J., and Verma I.M. Transcription of c-onc genes c-rasKi and c-fms during mouse development. Mol. Cell. Biol. 3 (1983) 1062-1069
31. Esteban L.M., Vicario-Abejon C., Fernandez-Salguero P., Fernandez-Medarde A., Swaminathan N., Yienger K., Lopez E., Malumbres M., McKay R., Ward J.M., Pellicer A., and Santos E. Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development. Mol. Cell. Biol. 21 (2001) 1444-1452
32. Johnson L., Greenbaum D., Cichowski K., Mercer K., Murphy E., Schmitt E., Bronson R.T., Umanoff H., Edelmann W., Kucherlapati R., and Jacks T. K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev. 11 (1997) 2468-2481
33. Koera K., Nakamura K., Nakao K., Miyoshi J., Toyoshima K., Hatta T., Otani H., Aiba A., and Katsuki M. K-ras is essential for the development of the mouse embryo. Oncogene 15 (1997) 1151-1159
34. Umanoff H., Edelmann W., Pellicer A., and Kucherlapati R. The murine N-ras gene is not essential for growth and development. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 1709-1713
35. Bos J.L. ras oncogenes in human cancer: a review. Cancer Res. 49 (1989) 4682-4689
36. Hancock J.F., and Parton R.G. Ras plasma membrane signalling platforms. Biochem. J. 389 (2005) 1-11
37. Hancock J.F., Paterson H., and Marshall C.J. A polybasic domain or palmitoylation is required in addition to the CAAX motif to localize p21ras to the plasma membrane. Cell 63 (1990) 133-139
38. Lobo S., Greentree W.K., Linder M.E., and Deschenes R.J. Identification of a Ras palmitoyltransferase in Saccharomyces cerevisiae. J. Biol. Chem. 277 (2002) 41268-41273
39. Mukherjee S., and Maxfield F.R. Membrane domains. Annu. Rev. Cell Dev. Biol. 20 (2004) 839-866
40. Hancock J.F., Magee A.I., Childs J.E., and Marshall C.J. All ras proteins are polyisoprenylated but only some are palmitoylated. Cell 57 (1989) 1167-1177
41. Choy E., Chiu V.K., Silletti J., Feoktistov M., Morimoto T., Michaelson D., Ivanov I.E., and Philips M.R. Endomembrane trafficking of ras: the CAAX motif targets proteins to the ER and Golgi. Cell 98 (1999) 69-80
42. Chen Z., Otto J.C., Bergo M.O., Young S.G., and Casey P.J. The C-terminal polylysine region and methylation of K-Ras are critical for the interaction between K-Ras and microtubules. J. Biol. Chem. 275 (2000) 41251-41257
43. Thissen J.A., Gross J.M., Subramanian K., Meyer T., and Casey P.J. Prenylation-dependent association of Ki-Ras with microtubules. Evidence for a role in subcellular trafficking. J. Biol. Chem. 272 (1997) 30362-30370
44. Jura N., Scotto-Lavino E., Sobczyk A., and Bar-Sagi D. Differential modification of Ras proteins by ubiquitination. Mol. Cell 21 (2006) 679-687
45. Liu P., Ying Y., and Anderson R.G.W. Platelet-derived growth factor activates mitogen-activated protein kinase in isolated caveolae. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 13666-13670
46. Prior I.A., Harding A., Yan J., Sluimer J., Parton R.G., and Hancock J.F. GTP-dependent segregation of H-ras from lipid rafts is required for biological activity. Nat. Cell Biol. 3 (2001) 368-375
47. Roy S., Plowman S., Rotblat B., Prior I.A., Muncke C., Grainger S., Parton R.G., Henis Y.I., Kloog Y., and Hancock J.F. Individual palmitoyl residues serve distinct roles in H-ras trafficking, microlocalization, and signaling. Mol. Cell. Biol. 25 (2005) 6722-6733
48. Jaumot M., Yan J., Clyde-Smith J., Sluimer J., and Hancock J.F. The linker domain of the Ha-Ras hypervariable region regulates interactions with exchange factors, Raf-1 and phosphoinositide 3-kinase. J. Biol. Chem. 277 (2002) 272-278
49. Paz A., Haklai R., Elad-Sfadia G., Ballan E., and Kloog Y. Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation. Oncogene 20 (2001) 7486-7493
50. Elad-Sfadia G., Haklai R., Ballan E., Gabius H.J., and Kloog Y. Galectin-1 augments Ras activation and diverts Ras signals to Raf-1 at the expense of phosphoinositide 3-kinase. J. Biol. Chem. 277 (2002) 37169-37175
51. Elad-Sfadia G., Haklai R., Balan E., and Kloog Y. Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase activity. J. Biol. Chem. 279 (2004) 34922-34930
52. Nancy V., Callebaut I., El Marjou A., and de Gunzburg J. The delta subunit of retinal rod cGMP phosphodiesterase regulates the membrane association of Ras and Rap GTPases. J. Biol. Chem. 277 (2002) 15076-15084
53. Wu Y., and Han M. Suppression of activated Let-60 ras protein defines a role of Caenorhabditis elegans Sur-1 MAP kinase in vulval differentiation. Genes Dev. 8 (1994) 147-159
54. Di Guglielmo G.M., Baass P.C., Ou W.J., Posner B.I., and Bergeron J.J. Compartmentalization of SHC, GRB2 and mSOS, and hyperphosphorylation of Raf-1 by EGF but not insulin in liver parenchyma. EMBO J. 13 (1994) 4269-4277
55. Daaka Y., Luttrell L.M., Ahn S., Della Rocca G.J., Ferguson S.S., Caron M.G., and Lefkowitz R.J. Essential role for G protein-coupled receptor endocytosis in the activation of mitogen-activated protein kinase. J. Biol. Chem. 273 (1998) 685-688
56. Zhang Y., Moheban D.B., Conway B.R., Bhattacharyya A., and Segal R.A. Cell surface Trk receptors mediate NGF-induced survival while internalized receptors regulate NGF-induced differentiation. J. Neurosci. 20 (2000) 5671-5678
57. Chiu V.K., Bivona T., Hach A., Sajous J.B., Silletti J., Wiener H., Johnson R.L., Cox A.D., and Philips M.R. Ras signalling on the endoplasmic reticulum and the Golgi. Nat. Cell Biol. 4 (2002) 343-350
58. Mor A., and Philips M.R. Compartmentalized Ras/MAPK signaling. Annu. Rev. Immunol. 24 (2006) 771-800
59. Robubi A., Mueller T., Fueller J., Hekman M., Rapp U.R., and Dandekar T. B-Raf and C-Raf signaling investigated in a simplified model of the mitogenic kinase cascade. Biol. Chem. 386 (2005) 1165-1171
60. Wixler V., Smola U., Schuler M., and Rapp U. Differential regulation of Raf isozymes by growth versus differentiation inducing factors in PC12 pheochromocytoma cells. FEBS Lett. 385 (1996) 131-137
61. York R.D., Yao H., Dillon T., Ellig C.L., Eckert S.P., McCleskey E.W., and Stork P.J.S. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor. Nature 392 (1998) 622-626
62. Sasagawa S., Ozaki Y.i., Fujita K., and Kuroda S. Prediction and validation of the distinct dynamics of transient and sustained ERK activation. Nat. Cell Biol. 7 (2005) 365-373
63. Downward J. The GRB2/Sem-5 adaptor protein. FEBS Lett. 338 (1994) 113-117
64. Avraham H., Park S.Y., Schinkmann K., and Avraham S. RAFTK/Pyk2-mediated cellular signalling. Cell. Signal. 12 (2000) 123-133
65. Sondermann H., Soisson S.M., Boykevisch S., Yang S.S., Bar-Sagi D., and Kuriyan J. Structural analysis of autoinhibition in the Ras activator Son of sevenless. Cell 119 (2004) 393-405
66. Margarit S.M., Sondermann H., Hall B.E., Nagar B., Hoelz A., Pirruccello M., Bar-Sagi D., and Kuriyan J. Structural evidence for feedback activation by Ras.GTP of the Ras-specific nucleotide exchange factor SOS. Cell 112 (2003) 685-695
67. Mitin N., Rossman K.L., and Der C.J. Signaling interplay in Ras superfamily function. Curr. Biol. 15 (2005) R563-R574
68. Krapivinsky G., Krapivinsky L., Manasian Y., Ivanov A., Tyzio R., Pellegrino C., Ben-Ari Y., Clapham D.E., and Medina I. The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1. Neuron 40 (2003) 775-784
69. Tian X., Gotoh T., Tsuji K., Lo E.H., Huang S., and Feig L.A. Developmentally regulated role for Ras-GRFs in coupling NMDA glutamate receptors to Ras, Erk and CREB. EMBO J. 23 (2004) 1567-1575
70. Tognon C.E., Kirk H.E., Passmore L.A., Whitehead I.P., Der C.J., and Kay R.J. Regulation of RasGRP via a phorbol ester-responsive C1 domain. Mol. Cell. Biol. 18 (1998) 6995-7008
71. Ebinu J.O., Bottorff D.A., Chan E.Y., Stang S.L., Dunn R.J., and Stone J.C. RasGRP, a Ras guanyl nucleotide-releasing protein with calcium- and diacylglycerol-binding motifs. Science 280 (1998) 1082-1086
72. Caloca M.J., Zugaza J.L., and Bustelo X.R. Exchange factors of the RasGRP family mediate Ras activation in the Golgi. J. Biol. Chem. 278 (2003) 33465-33473
73. Clyde-Smith J., Silins G., Gartside M., Grimmond S., Etheridge M., Apolloni A., Hayward N., and Hancock J.F. Characterization of RasGRP2, a plasma membrane-targeted, dual specificity Ras/Rap exchange factor. J. Biol. Chem. 275 (2000) 32260-32267
74. Dower N.A., Stang S.L., Bottorff D.A., Ebinu J.O., Dickie P., Ostergaard H.L., and Stone J.C. RasGRP is essential for mouse thymocyte differentiation and TCR signaling. Nat. Immunol. 1 (2000) 317-321
75. Crittenden J.R., Bergmeier W., Zhang Y., Piffath C.L., Liang Y., Wagner D.D., Housman D.E., and Graybiel A.M. CalDAG-GEFI integrates signaling for platelet aggregation and thrombus formation. Nat. Med. 10 (2004) 982-986
76. Adari H., Lowy D.R., Willumsen B.M., Der C.J., and McCormick F. Guanosine triphosphatase activating protein(GAP) interacts with the p 21 ras effector binding domain. Science 240 (1988) 518-521
77. Kaplan D.R., Morrison D.K., Wong G., McCormick F., and Williams L.T. PDGF beta-receptor stimulates tyrosine phosphorylation of GAP and association of GAP with a signaling complex. Cell 61 (1990) 125-133
78. Kazlauskas A., Ellis C., Pawson T., and Cooper J.A. Binding of GAP to activated PDGF receptors. Science 247 (1990) 1578-1581
79. Yang J.Y., Michod D., Walicki J., Murphy B.M., Kasibhatla S., Martin S.J., and Widmann C. Partial cleavage of RasGAP by caspases is required for cell survival in mild stress conditions. Mol. Cell. Biol. 24 (2004) 10425-10436
80. Cichowski K., Santiago S., Jardim M., Johnson B.W., and Jacks T. Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressor. Genes Dev. 17 (2003) 449-454
81. Johannessen C.M., Reczek E.E., James M.F., Brems H., Legius E., and Cichowski K. The NF1 tumor suppressor critically regulates TSC2 and mTOR. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 8573-8578
82. Lockyer P.J., Kupzig S., and Cullen P.J. CAPRI regulates Ca 2+-dependent inactivation of the Ras-MAPK pathway. Curr. Biol. 11 (2001) 981-986
83. Allen M., Chu S., Brill S., Stotler C., and Buckler A. Restricted tissue expression pattern of a novel human rasGAP-related gene and its murine ortholog. Gene 218 (1998) 17-25
84. Walker S.A., Kupzig S., Bouyoucef D., Davies L.C., Tsuboi T., Bivona T.G., Cozier G.E., Lockyer P.J., Buckler A., and Rutter G.A. Identification of a Ras GTPase-activating protein regulated by receptor-mediated Ca 2+ oscillations. EMBO J. 23 (2004) 1749-1760
85. Cullen P.J., Hsuan J.J., Truong O., Letcher A.J., Jackson T.R., Dawson A.P., and Irvine R.F. Identification of a specific Ins(1,3,4,5)P4-binding protein as a member of the GAP1 family. Nature 376 (1995) 527-530
86. Lockyer P.J., Wennstrom S., Kupzig S., Venkateswarlu K., Downward J., and Cullen P.J. Identification of the ras GTPase-activating protein GAP1(m) as a phosphatidylinositol-3,4,5-trisphosphate-binding protein in vivo. Curr. Biol. 9 (1999) 265-268
87. Kim J.H., Liao D., Lau L.F., and Huganir R.L. SynGAP: a synaptic RasGAP that associates with the PSD-95/SAP90 protein family. Neuron 20 (1998) 683-691
88. Rumbaugh G., Adams J.P., Kim J.H., and Huganir R.L. SynGAP regulates synaptic strength and mitogen-activated protein kinases in cultured neurons. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 4344-4351
89. Armelin H.A., Armelin M.C., Kelly K., Stewart T., Leder P., Cochran B.H., and Stiles C.D. Functional role for c-myc in mitogenic response to platelet-derived growth factor. Nature 310 (1984) 655-660
90. Blasi E., Mathieson B.J., Varesio L., Cleveland J.L., Borchert P.A., and Rapp U.R. Selective immortalization of murine macrophages from fresh bone marrow by a raf/myc recombinant murine retrovirus. Nature 318 (1985) 667-670
91. Rapp U.R., Cleveland J.L., Brightman K., Scott A., and Ihle J.N. Abrogation of IL-3 and IL-2 dependence by recombinant murine retroviruses expressing v-myc oncogenes. Nature 317 (1985) 434-438
92. Rapp U.R., Cleveland J.L., Storm S.M., Beck T.W., and Huleihel M. Transformation by raf and myc oncogenes. Princess Takamatsu Symp. 17 (1986) 55-74
93. Rapp U.R., Cleveland J.L., Bonner T.I., and Storm S.M. The Raf oncogene family. In: Curran T., Reddy E.P., and Skalka A. (Eds). The Oncogene Handbook (1988), The Elsevier Science Publishers, The Netherlands 213-253
94. Kyriakis J.M., App H., Zhang X.F., Banerjee P., Brautigan D.L., Rapp U.R., and Avruch J. Raf-1 activates MAP kinase-kinase. Nature 358 (1992) 417-421
95. Romero F. Aiolos transcription factor controls cell death in Tcells by regulating Bcl-2 expression and its cellular localization. EMBO J. 18 (1999) 3419-3430
96. Singh A., Sowjanya A.P., and Ramakrishna G. The wild-type Ras: road ahead. FASEB J. 19 (2005) 161-169
97. Repasky G.A., Chenette E.J., and Der C.J. Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis?. Trends Cell Biol. 14 (2004) 639-647
98. Herrmann C. Ras-effector interactions: after one decade. Curr. Opin. Struct. Biol. 13 (2003) 122-129
99. Rapp U.R., Goldsborough M.D., Mark G.E., Bonner T.I., Groffen J., Reynolds Jr. F.H., and Stephenson J.R. Structure and biological activity of v-raf, a unique oncogene transduced by a retrovirus. Proc. Natl. Acad. Sci. U. S. A. 80 (1983) 4218-4222
100. Jansen H.W., Patschinsky T., and Bister K. Avian oncovirus MH2: molecular cloning of proviral DNA and structural analysis of viral RNA and protein. J. Virol. 48 (1983) 61-73
101. Jansen H.W., Lurz R., Bister K., Bonner T.I., Mark G.E., and Rapp U.R. Homologous cell-derived oncogenes in avian carcinoma virus MH2 and murine sarcoma virus 3611. Nature 307 (1984) 281-284
102. Kamata T., and Feramisco J.R. Epidermal growth factor stimulates guanine nucleotide binding activity and phosphorylation of ras oncogene proteins. Nature 310 (1984) 147-150
103. Smith M.R., DeGudicibus S.J., and Stacey D.W. Requirement for c-ras proteins during viral oncogene transformation. Nature 320 (1986) 540-543
104. Rapp U.R., Bruder J.T., and Troppmair J. Role of the Raf signal transduction pathway in Fos/Jun regulation and determination of cell fates. In: Angel P.E., and Herrlich P.A. (Eds). The FOS and JUN Families of Transcription Factors (1994), CRC Press, Boca Raton 221-247
105. Kolch W., Heidecker G., Lloyd P., and Rapp U.R. Raf-1 protein kinase is required for growth of induced NIH/3T3 cells. Nature 349 (1991) 426-428
106. Bruder J.T., Heidecker G., and Rapp U.R. Serum-, TPA-, and Ras-induced expression from Ap-1/Ets-driven promoters requires Raf-1 kinase. Genes Dev. 6 (1992) 545-556
107. Troppmair J., Bruder J.T., App H., Cai H., Liptak L., Szeberenyi J., Cooper G.M., and Rapp U.R. Ras controls coupling of growth factor receptors and protein kinase C in the membrane to Raf-1 and B-Raf protein serine kinases in the cytosol. Oncogene 7 (1992) 1867-1873
108. Kolch W., Heidecker G., Kochs G., Hummel R., Vahidi H., Mischak H., Finkenzeller G., Marme D., and Rapp U.R. Protein kinase C alpha activates RAF-1 by direct phosphorylation. Nature 364 (1993) 249-252
109. Bourne H.R., Sanders D.A., and McCormick F. The GTPase superfamily: a conserved switch for diverse cell functions. Nature 348 (1990) 125-132
110. Bourne H.R., Sanders D.A., and McCormick F. The GTPase superfamily: conserved structure and molecular mechanism. Nature 349 (1991) 117-127
111. Zhang X.F., Settleman J., Kyriakis J.M., Takeuchi-Suzuki E., Elledge S.J., Marshall M.S., Bruder J.T., Rapp U.R., and Avruch J. Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1. Nature 364 (1993) 308-313
112. Hekman M., Hamm H., Villar A.V., Bader B., Kuhlmann J., Nickel J., and Rapp U.R. Associations of B- and C-Raf with cholesterol, phosphatidylserine, and lipid second messengers: preferential binding of Raf to artificial lipid rafts. J. Biol. Chem. 277 (2002) 24090-24102
113. Moodie S.A., Willumsen B.M., Weber M.J., and Wolfman A. Complexes of Ras.GTP with Raf-1 and mitogen-activated protein kinase kinase. Science 260 (1993) 1658-1661
114. Vojtek A.B., Hollenberg S.M., and Cooper J.A. Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell 74 (1993) 205-214
115. Warne P.H., Viciana P.R., and Downward J. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro. Nature 364 (1993) 352-355
116. Rapp U.R., Gotz R., and Albert S. BuCy RAFs drive cells into MEK addiction. Cancer Cell 9 (2006) 9-12
117. Voice J.K., Klemke R.L., Le A., and Jackson J.H. Four human Ras homologs differ in their abilities to activate Raf-1, induce transformation, and stimulate cell motility. J. Biol. Chem. 274 (1999) 17164-17170
118. Hancock J.F. Ras proteins: different signals from different locations. Nat. Rev., Mol. Cell Biol. 4 (2003) 373-384
119. Hekman M., Wiese S., Metz R., Albert S., Troppmair J., Nickel J., Sendtner M., and Rapp U.R. Dynamic changes in C-Raf phosphorylation and 14-3-3 protein binding in response to growth factor stimulation: differential roles of 14-3-3 protein binding sites. J. Biol. Chem. 279 (2004) 14074-14086
120. Rajalingam K., Wunder C., Brinkmann V., Churin Y., Hekman M., Sievers C., Rapp U.R., and Rudel T. Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration. Nat. Cell Biol. 7 (2005) 837-843
121. Rajalingam K., and Rudel T. Ras-Raf signaling needs prohibitin. Cell Cycle 4 (2005) 1503-1505
122. Schreck R., and Rapp U.R. Raf kinases: oncogenesis and drug discovery. Int. J. Cancer 119 (2006) 2261-2271
123. Kyriakis J.M. The integration of signaling by multiprotein complexes containing Raf kinases. Biochim. Biophys. Acta 1773 (2007) 1238-1247 10.1016/j.bbamcr.2006.11.003
124. Rodriguez-Viciana P., Warne P.H., Dhand R., Vanhaesebroeck B., Gout I., Fry M.J., Waterfield M.D., and Downward J. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370 (1994) 527-532
125. Sjolander A., Yamamoto K., Huber B.E., and Lapetina E.G. Association of p21ras with phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 7908-7912
126. Yan J., Roy S., Apolloni A., Lane A., and Hancock J.F. Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase. J. Biol. Chem. 273 (1998) 24052-24056
127. Cully M., You H., Levine A.J., and Mak T.W. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat. Rev., Cancer 6 (2006) 184-192
128. Scheid M.P., and Woodgett J.R. Phosphatidylinositol 3′ kinase signaling in mammary tumorigenesis. J. Mammary Gland Biol. Neoplasia 6 (2001) 83-99
129. Scheid M.P., and Woodgett J.R. PKB/AKT: functional insights from genetic models. Nat. Rev., Mol. Cell Biol. 2 (2001) 760-768
130. Luo J., Manning B.D., and Cantley L.C. Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell 4 (2003) 257-262
131. Feinstein E. Ral-GTPases: good chances for a long-lasting fame. Oncogene 24 (2005) 326-328
132. Rangarajan A., Hong S.J., Gifford A., and Weinberg R.A. Species- and cell type-specific requirements for cellular transformation. Cancer Cell 6 (2004) 171-183
133. Chien Y., and White M.A. RAL GTPases are linchpin modulators of human tumour-cell proliferation and survival. EMBO Rep. 4 (2003) 800-806
134. Rosse C., Hatzoglou A., Parrini M.C., White M.A., Chavrier P., and Camonis J. RalB mobilizes the exocyst to drive cell migration. Mol. Cell. Biol. 26 (2006) 727
135. Camonis J.H., and White M.A. Ral GTPases: corrupting the exocyst in cancer cells. Trends Cell Biol. 15 (2005) 327-332
136. Feig L.A. Ral-GTPases: approaching their 15 minutes of fame. Trends Cell Biol. 13 (2003) 419-425
137. Habets G.G., Scholtes E.H., Zuydgeest D., van der Kammen R.A., Stam J.C., Berns A., and Collard J.G. Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins. Cell 77 (1994) 537-549
138. Lambert J.M., Lambert Q.T., Reuther G.W., Malliri A., Siderovski D.P., Sondek J., Collard J.G., and Der C.J. Tiam1 mediates Ras activation of Rac by a PI(3)K-independent mechanism. Nat. Cell Biol. 4 (2002) 621-625
139. Malliri A., van der Kammen R.A., Clark K., van der Valk M., Michiels F., and Collard J.G. Mice deficient in the Rac activator Tiam 1 are resistant to Ras-induced skin tumours. Nature 417 (2002) 867-871
140. Yamauchi J., Miyamoto Y., Tanoue A., Shooter E.M., and Chan J.R. Ras activation of a Rac1 exchange factor, Tiam1, mediates neurotrophin-3-induced Schwann cell migration. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 14889-14894
141. Yamauchi J., Chan J.R., Miyamoto Y., Tsujimoto G., and Shooter E.M. The neurotrophin-3 receptor TrkC directly phosphorylates and activates the nucleotide exchange factor Dbs to enhance Schwann cell migration. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 5198-5203
142. Arthur W.T., Quilliam L.A., and Cooper J.A. Rap1 promotes cell spreading by localizing Rac guanine nucleotide exchange factors. J. Cell Biol. 167 (2004) 111-122
143. Mertens A.E., Roovers R.C., and Collard J.G. Regulation of Tiam1-Rac signalling. FEBS Lett. 546 (2003) 11-16
144. Tommasi S., Dammann R., Jin S.G., Zhang X., Avruch X.J., and Pfeifer G.P. RASSF3 and NORE1: identification and cloning of two human homologues of the putative tumor suppressor gene RASSF1. Oncogene 21 (2002) 2713-2720
145. Dammann R., Li C., Yoon J.H., Chin P.L., Bates S., and Pfeifer G.P. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat. Genet. 25 (2000) 315-319
146. Vos M.D., Martinez A., Ellis C.A., Vallecorsa T., and Clark G.J. The pro-apoptotic Ras effector Nore1 may serve as a Ras-regulated tumor suppressor in the lung. J. Biol. Chem. 278 (2003) 21938-21943
147. Vos M.D., Ellis C.A., Elam C., Ulku A.S., Taylor B.J., and Clark G.J. RASSF2 is a novel K-Ras-specific effector and potential tumor suppressor. J. Biol. Chem. 278 (2003) 28045-28051
148. Akino K., Toyota M., Suzuki H., Mita H., Sasaki Y., Ohe-Toyota M., Issa J.P., Hinoda Y., Imai K., and Tokino T. The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer. Gastroenterology 129 (2005) 156-169
149. Baksh S., Tommasi S., Fenton S., Yu V.C., Martins L.M., Pfeifer G.P., Latif F., Downward J., and Neel B.G. The tumor suppressor RASSF1A and MAP-1 link death receptor signaling to Bax conformational change and cell death. Mol. Cell 18 (2005) 637-650
150. Khokhlatchev A., Rabizadeh S., Xavier R., Nedwidek M., Chen T., Zhang X.F., Seed B., and Avruch J. Identification of a novel Ras-regulated proapoptotic pathway. Curr. Biol. 12 (2002) 253-265
151. Tall G.G., Barbieri M.A., Stahl P.D., and Horazdovsky B.F. Ras-activated endocytosis is mediated by the Rab5 guanine nucleotide exchange activity of RIN1. Dev. Cell 1 (2001) 73-82
152. Shibatohge M., Kariya K.i., Liao Y., Hu C.D., Watari Y., Goshima M., Shima F., and Kataoka T. Identification of PLC210, a Caenorhabditis elegans phospholipase C, as a putative effector of Ras. J. Biol. Chem. 273 (1998) 6218-6222
153. Jin T.G., Satoh T., Liao Y., Song C., Gao X., Kariya K.i., Hu C.D., and Kataoka T. Role of the CDC25 homology domain of phospholipase cepsilon in amplification of Rap1-dependent signaling. J. Biol. Chem. 276 (2001) 30301-30307
154. Song C., Satoh T., Edamatsu H., Wu D., Tadano M., Gao X., and Kataoka T. Differential roles of Ras and Rap1 in growth factor-dependent activation of phospholipase C epsilon. Oncogene 21 (2002) 8105-8113
155. Bai Y., Edamatsu H., Maeda S., Saito H., Suzuki N., Satoh T., and Kataoka T. Crucial role of phospholipase Cepsilon in chemical carcinogen-induced skin tumor development. Cancer Res. 64 (2004) 8808-8810
156. Zhadanov A.B., Provance Jr. D.W., Speer C.A., Coffin J.D., Goss D., Blixt J.A., Reichert C.M., and Mercer J.A. Absence of the tight junctional protein AF-6 disrupts epithelial cell-cell junctions and cell polarity during mouse development. Curr. Biol. 9 (1999) 880-888
157. Zhang Z., Rehmann H., Price L.S., Riedl J., and Bos J.L. AF6 negatively regulates Rap1-induced cell adhesion. J. Biol. Chem. 280 (2005) 33200-33205
158. Toker A. Signaling through protein kinase C. Front. Biosci. 3 (1998) D1134-D1147
159. Marshall M.S. Ras target proteins in eukaryotic cells. FASEB J. 9 (1995) 1311-1318
160. Prasad R., Gu Y., Alder H., Nakamura T., Canaani O., Saito H., Huebner K., Gale R.P., Nowell P.C., and Kuriyama K. Cloning of the ALL-1 fusion partner, the AF-6 gene, involved in acute myeloid leukemias with the t(6;11) chromosome translocation. Cancer Res. 53 (1993) 5624-5628
161. Kuriyama M., Harada N., Kuroda S., Yamamoto T., Nakafuku M., Iwamatsu A., Yamamoto D., Prasad R., Croce C., Canaani E., and Kaibuchi K. Identification of AF-6 and canoe as putative targets for Ras. J. Biol. Chem. 271 (1996) 607-610
162. Diaz-Meco M.T., Lozano J., Municio M.M., Berra E., Frutos S., Sanz L., and Moscat J. Evidence for the in vitro and in vivo interaction of Ras with protein kinase C zeta. J. Biol. Chem. 269 (1994) 31706-31710
163. Moscat J., Rennert P., and az-Meco M.T. PKC[zeta] at the crossroad of NF-[kappa]B and Jak1//Stat6 signaling pathways. Cell Death Differ. 13 (2005) 702-711
164. Joseph T., Bryant A., Frankel P., Wooden R., Kerkhoff E., Rapp U.R., and Foster D.A. Phospholipase D overcomes cell cycle arrest induced by high-intensity Raf signaling. Oncogene 21 (2002) 3651-3658
165. Friday B.B., and Adjei A.A. K-ras as a target for cancer therapy. Biochim. Biophys. Acta 1756 (2005) 127-144
166. Whyte D.B., Kirschmeier P., Hockenberry T.N., Nunez-Oliva I., James L., Catino J.J., Bishop W.R., and Pai J.K. K- and N-Ras are geranylgeranylated in cells treated with farnesyl protein transferase inhibitors. J. Biol. Chem. 272 (1997) 14459-14464
167. Ahmadian M.R., Zor T., Vogt D., Kabsch W., Selinger Z., Wittinghofer A., and Scheffzek K. Guanosine triphosphatase stimulation of oncogenic Ras mutants. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 7065-7070
168. Kosloff M., and Selinger Z. Substrate assisted catalysis-Application to G proteins. Trends Biochem. Sci. 26 (2001) 161-166
169. Spoerner M., Graf T., Konig B., and Kalbitzer H.R. A novel mechanism for the modulation of the Ras-effector interaction by small molecules. Biochem. Biophys. Res. Commun. 334 (2005) 709-713
170. Solit D.B., Garraway L.A., Pratilas C.A., Sawai A., Getz G., Basso A., Ye Q., Lobo J.M., She Y., Osman I., Golub T.R., Sebolt-Leopold J., Sellers W.R., and Rosen N. BRAF mutation predicts sensitivity to MEK inhibition. Nature 439 (2006) 358-362
171. Wang Y., Van B.K., Jiang P., Przybranowski S., Omer C., and Sebolt-Leopold J. A role for K-ras in conferring resistance to the MEK inhibitor, CI-1040. Neoplasia 7 (2005) 336-347
172. Johnson S.M., Grosshans H., Shingara J., Byrom M., Jarvis R., Cheng A., Labourier E., Reinert K.L., Brown D., and Slack F.J. RAS is regulated by the let-7 microRNA family. Cell 120 (2005) 635-647
173. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 (2004) 281-297
174. Bentwich I., Avniel A., Karov Y., Aharonov R., Gilad S., Barad O., Barzilai A., Einat P., Einav U., Meiri E., Sharon E., Spector Y., and Bentwich Z. Identification of hundreds of conserved and nonconserved human microRNAs. Nat. Genet. 37 (2005) 766-770
175. Lewis B.P., Burge C.B., and Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120 (2005) 15-20
176. Calin G.A., Dumitru C.D., Shimizu M., Bichi R., Zupo S., Noch E., Aldler H., Rattan S., Keating M., Rai K., Rassenti L., Kipps T., Negrini M., Bullrich F., and Croce C.M. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 15524-15529
177. Esquela-Kerscher A., and Slack F.J. Oncomirs-MicroRNAs with a role in cancer. Nat. Rev., Cancer 6 (2006) 259-269
178. Hammond S.M. MicroRNAs as oncogenes. Curr. Opin. Genet. Dev. 16 (2006) 4-9
179. Lee Y.S., and Dutta A. MicroRNAs: small but potent oncogenes or tumor suppressors. Curr. Opin. Investig. Drugs 7 (2006) 560-564
180. Reinhart B.J., Slack F.J., Basson M., Pasquinelli A.E., Bettinger J.C., Rougvie A.E., Horvitz H.R., and Ruvkun G. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403 (2000) 901-906
181. Bagga S., Bracht J., Hunter S., Massirer K., Holtz J., Eachus R., and Pasquinelli A.E. Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell 122 (2005) 553-563
182. Calin G.A., Sevignani C., Dumitru C.D., Hyslop T., Noch E., Yendamuri S., Shimizu M., Rattan S., Bullrich F., Negrini M., and Croce C.M. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 2999-3004
183. Takamizawa J., Konishi H., Yanagisawa K., Tomida S., Osada H., Endoh H., Harano T., Yatabe Y., Nagino M., Nimura Y., Mitsudomi T., and Takahashi T. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 64 (2004) 3753-3756
184. Yanaihara N., Caplen N., Bowman E., Seike M., Kumamoto K., Yi M., Stephens R.M., Okamoto A., Yokota J., Tanaka T., Calin G.A., Liu C.G., Croce C.M., and Harris C.C. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9 (2006) 189-198
185. Vogelstein B., and Kinzler K.W. The multistep nature of cancer. Trends Genet. 9 (1993) 138-141
186. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
187. COSMIC, http://www.Sanger.Ac.Uk/Genetics/CGP/Cosmic/.
188. Sieber O.M., Tomlinson S.R., and Tomlinson I.P. Tissue, cell and stage specificity of (epi)mutations in cancers. Nat. Rev., Cancer 5 (2005) 649-655
189. Bentires-Alj M., Kontaridis M.I., and Neel B.G. Stops along the RAS pathway in human genetic disease. Nat. Med. 12 (2006) 283-285
190. Roberts A., Allanson J., Jadico S.K., Kavamura M.I., Noonan J., Opitz J.M., Young T., and Neri G. The cardiofaciocutaneous syndrome. J. Med. Genet. 43 (2006) 833-842
191. Tartaglia M., and Gelb B.D. Noonan syndrome and related disorders: genetics and pathogenesis. Annu. Rev. Genomics Hum. Genet. 6 (2005) 45-68
192. Schubbert S., Zenker M., Rowe S.L., Boll S., Klein C., Bollag G., van der Burgt I., Musante L., Kalscheuer V., Wehner L.E., Nguyen H., West B., Zhang K.Y., Sistermans E., Rauch A., Niemeyer C.M., Shannon K., and Kratz C.P. Germline KRAS mutations cause Noonan syndrome. Nat. Genet. 38 (2006) 331-336
193. Niihori T., Aoki Y., Narumi Y., Neri G., Cave H., Verloes A., Okamoto N., Hennekam R.C., Gillessen-Kaesbach G., Wieczorek D., Kavamura M.I., Kurosawa K., Ohashi H., Wilson L., Heron D., Bonneau D., Corona G., Kaname T., Naritomi K., and Baumann C. Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome. Nat. Genet. 38 (2006) 294-296
194. Aoki Y., Niihori T., Kawame H., Kurosawa K., Ohashi H., Tanaka Y., Filocamo M., Kato K., Suzuki Y., Kure S., and Matsubara Y. Germline mutations in HRAS proto-oncogene cause Costello syndrome. Nat. Genet. 37 (2005) 1038-1040
195. Estep A.L., Tidyman W.E., Teitell M.A., Cotter P.D., and Rauen K.A. HRAS mutations in Costello syndrome: detection of constitutional activating mutations in codon 12 and 13 and loss of wild-type allele in malignancy. Am. J. Med. Genet., Part A 140 (2006) 8-16
196. Gripp K.W., Lin A.E., Stabley D.L., Nicholson L., Scott Jr. C.I., Doyle D., Aoki Y., Matsubara Y., Zackai E.H., Lapunzina P., Gonzalez-Meneses A., Holbrook J., Agresta C.A., Gonzalez I.L., and Sol-Church K. HRAS mutation analysis in Costello syndrome: genotype and phenotype correlation. Am. J. Med. Genet., Part A 140 (2006) 1-7
197. Kerr B., Delrue M.A., Sigaudy S., Perveen R., Marche M., Burgelin I., Stef M., Tang B., Eden O.B., O'Sullivan J., De Sandre-Giovannoli A., Reardon W., Brewer C., Bennett C., Quarell O., M'Cann E., Donnai D., Stewart F., Hennekam R., and Cave H. Genotype-phenotype correlation in Costello syndrome: HRAS mutation analysis in 43 cases. J. Med. Genet. 43 (2006) 401-405
198. Rodriguez-Viciana P., Tetsu O., Tidyman W.E., Estep A.L., Conger B.A., Cruz M.S., McCormick F., and Rauen K.A. Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome. Science 311 (2006) 1287-1290
199. Young T., Mei F., Liu J., Bast Jr. R.C., Kurosky A., and Cheng X. Proteomics analysis of H-RAS-mediated oncogenic transformation in a genetically defined human ovarian cancer model. Oncogene 24 (2005) 6174-6184
200. Park J.W., Kim S., and Bahk Y.Y. A proteomic approach for dissecting H-Ras signaling networks in NIH/3T3 mouse embryonic fibroblast cells. Proteomics 6 (2006) 2433-2443
201. Park J.W., Kim S., Lim K.J., Simpson R.J., Kim Y.S., and Bahk Y.Y. A proteomic approach for unraveling the oncogenic H-Ras protein networks in NIH/3T3 mouse embryonic fibroblast cells. Proteomics 6 (2006) 1175-1186
202. Alfonso P., Dolado I., Swat A., Nunez A., Cuadrado A., Nebreda A.R., and Casal J.I. Proteomic analysis of p38alpha mitogen-activated protein kinase-regulated changes in membrane fractions of RAS-transformed fibroblasts. Proteomics 6 Suppl 1 (2006) S262-S271
203. Zuber J., Tchernitsa O.I., Hinzmann B., Schmitz A.C., Grips M., Hellriegel M., Sers C., Rosenthal A., and Schafer R. A genome-wide survey of RAS transformation targets. Nat. Genet. 24 (2000) 144-152
204. Cobellis G., Missero C., Simionati B., Valle G., and Di Lauro R. Immediate early genes induced by H-Ras in thyroid cells. Oncogene 20 (2001) 2281-2290
205. Tchernitsa O.I., Sers C., Zuber J., Hinzmann B., Grips M., Schramme A., Lund P., Schwendel A., Rosenthal A., and Schafer R. Transcriptional basis of KRAS oncogene-mediated cellular transformation in ovarian epithelial cells. Oncogene 23 (2004) 4536-4555
206. Qian J., Niu J., Li M., Chiao P.J., and Tsao M.S. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis. Cancer Res. 65 (2005) 5045-5053
207. Seiden-Long I.M., Brown K.R., Shih W., Wigle D.A., Radulovich N., Jurisica I., and Tsao M.S. Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer. Oncogene 25 (2006) 91-102
208. Bloethner S., Chen B., Hemminki K., Muller-Berghaus J., Ugurel S., Schadendorf D., and Kumar R. Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines. Carcinogenesis 26 (2005) 1224-1232
209. Sweet-Cordero A., Mukherjee S., Subramanian A., You H., Roix J.J., Ladd-Acosta C., Mesirov J., Golub T.R., and Jacks T. An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis. Nat. Genet. 37 (2005) 48-55
210. Kim I.J., Kang H.C., Jang S.G., Kim K., Ahn S.A., Yoon H.J., Yoon S.N., and Park J.G. Oligonucleotide microarray analysis of distinct gene expression patterns in colorectal cancer tissues harboring BRAF and K-ras mutations. Carcinogenesis 27 (2006) 392-404
211. Jonkers J., and Berns A. Oncogene addiction: sometimes a temporary slavery. Cancer Cell 6 (2004) 535-538
212. Weinstein I.B. Cancer. Addiction to oncogenes-The Achilles heal of cancer. Science 297 (2002) 63-64
213. Rajasekhar V.K., Viale A., Socci N.D., Wiedmann M., Hu X., and Holland E.C. Oncogenic Ras and Akt signaling contribute to glioblastoma formation by differential recruitment of existing mRNAs to polysomes. Mol. Cell 12 (2003) 889-901
214. Spence J., Duggan B.M., Eckhardt C., McClelland M., and Mercola D. Messenger RNAs under differential translational control in Ki-ras-transformed cells. Mol. Cancer Res. 4 (2006) 47-60
215. Rajasekhar V.K., and Holland E.C. Postgenomic global analysis of translational control induced by oncogenic signaling. Oncogene 23 (2004) 3248-3264
216. Janssen K.P., Abal M., El Marjou F., Louvard D., and Robine S. Mouse models of K-ras-initiated carcinogenesis. Biochim. Biophys. Acta 1756 (2005) 145-154
217. Kemp C.J. Multistep skin cancer in mice as a model to study the evolution of cancer cells. Semin. Cancer Biol. 15 (2005) 460-473
218. Guerra C., Mijimolle N., Dhawahir A., Dubus P., Barradas M., Serrano M., Campuzano V., and Barbacid M. Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. Cancer Cell 4 (2003) 111-120
219. Kim C.F., Jackson E.L., Woolfenden A.E., Lawrence S., Babar I., Vogel S., Crowley D., Bronson R.T., and Jacks T. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121 (2005) 823-835
220. Perez-Losada J., and Balmain A. Stem-cell hierarchy in skin cancer. Nat. Rev., Cancer 3 (2003) 434-443
221. Guo X., Stratton L., and Schrader J.W. Expression of activated M-Ras in hemopoietic stem cells initiates leukemogenic transformation, immortalization and preferential generation of mast cells. Oncogene 25 (2006) 4241-4244
222. Bernstein H.J. Recent changes to RasMol, recombining the variants. Trends Biochem. Sci. 25 (2000) 453-455
223. Tong L., Milburn M.V., de Vos A.M., and Kim S.H. Structure of ras proteins. Science 245 (1989) 244
224. Scheidig A.J., Burmester C., and Goody R.S. The pre-hydrolysis state of p21(ras) in complex with GTP: new insights into the role of water molecules in the GTP hydrolysis reaction of ras-like proteins. Structure 7 (1999) 1311-1324
225. Baldauf S.L. The deep roots of eukaryotes. Science 300 (2003) 1703-1706